AFG
BBIO icon

Atomi Financial Group’s BridgeBio Pharma BBIO Stock Holding History

Atomi Financial Group’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
2,778
+39
+1% +$2.73K 0.01% 1202
2026
Q1 		$203K Buy
2,739
+16
+0.6% +$1.16K 0.01% 1150
2025
Q4 		$208K Sell
2,723
-12,483
-82% -$819K 0.01% 1133
2025
Q3 		$790K Buy
15,206
+420
+3% +$20.5K 0.03% 465
2025
Q2 		$638K Buy
14,786
+420
+3% +$15.3K 0.02% 496
2025
Q1 		$497K Buy
14,366
+64
+0.4% +$2.16K 0.02% 540
2024
Q4 		$392K Buy
+14,302
New +$370K 0.02% 585

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Atomi Financial Group's BBIO Position: Q2 2026 in Review

Atomi Financial Group increased its BridgeBio Pharma (BBIO) stake by 1.4% in Q2 2026, buying an estimated $2.73K and bringing the position to 2,778 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #1202.

Atomi Financial Group first reported a position in BBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $790K in Q3 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Atomi Financial Group held 2,778 shares of BridgeBio Pharma worth $207K as of Q2 2026.
  • Atomi Financial Group bought 39 BridgeBio Pharma shares in Q2 2026, an estimated $2.73K.
  • BridgeBio Pharma made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #1202 holding.
  • Atomi Financial Group first reported a position in BridgeBio Pharma in Q4 2024 and has held it in 7 quarters since.
  • Atomi Financial Group's BridgeBio Pharma position peaked at $790K in Q3 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.